UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treatment of patients with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC) in Belgium: a real world data analysis

Acta clinica belgica (English ed. Online), 2022-11, Vol.77 (6), p.897-905

2022

Volltextzugriff (PDF)

Tilting a ground-state reactivity landscape by vibrational strong coupling

Science (American Association for the Advancement of Science), 2019-02, Vol.363 (6427), p.615-619

2019

Volltextzugriff (PDF)

Intestinal schwannoma

Journal belge de radiologie, 1997-12, Vol.80 (6), p.316

1997

Volltextzugriff (PDF)

Vaginal foreign body in the pediatric patient: A systematic review

European journal of obstetrics & gynecology and reproductive biology, 2024-06, Vol.297, p.153-158

2024

Volltextzugriff (PDF)

Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2010-02, Vol.138 (2), p.463-468

2010

Volltextzugriff (PDF)

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

The lancet oncology, 2019-06, Vol.20 (6), p.849-861

2019

Volltextzugriff (PDF)

Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology

Annals of oncology, 2013-11, Vol.24 (11), p.2824-2829

2013

Volltextzugriff (PDF)

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial

The Lancet infectious diseases, 2012-04, Vol.12 (4), p.281-289

2012

Volltextzugriff (PDF)

Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015

Annals of oncology, 2008-05, Vol.19 (5), p.920-926

2008

Volltextzugriff (PDF)

Boerhaave's syndrome: successful conservative treatment in two patients

Acta gastro-enterologica belgica, 2020-10, Vol.83 (4), p.654-656

2020

Volltextzugriff (PDF)

Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials

Clinical infectious diseases, 2012-08, Vol.55 (suppl_2), p.S93-S103

2012

Volltextzugriff (PDF)

The Psychological Science Accelerator: Advancing Psychology Through a Distributed Collaborative Network

Advances in methods and practices in psychological science, 2018-12, Vol.1 (4), p.501-515

2018

Volltextzugriff (PDF)

A two arm phase II study of FOLFIRI in combination with standard or escalating dose of cetuximab as first line treatment for metastatic colorectal cancer: Everest 2 final results

Annals of oncology, 2018-06, Vol.29, p.v105-v105

2018

Volltextzugriff (PDF)

REGINA: A phase II trial of neoadjuvant regorafenib (Rego) in combination with nivolumab (Nivo) and short-course radiotherapy (SCRT) in intermediate-risk, stage II-III rectal cancer (RC)

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.TPS226-TPS226

2022

Volltextzugriff (PDF)

O-015A two arm phase II study of FOLFIRI in combination with standard or escalating dose of cetuximab as first line treatment for metastatic colorectal cancer: Everest 2 final results

Annals of oncology, 2018-06, Vol.29 (suppl_5)

2018

Volltextzugriff (PDF)

AVAPLUS: Impact of geriatric assessment on first-line treatment duration (TD) and progression free survival (PFS) in mCRC patients ≥ 70 years

Annals of oncology, 2016-10, Vol.27, p.vi180-vi180

2016

Volltextzugriff (PDF)

PD-030Prospective non-interventional study to collect data on the use of bevacizumab and conventional chemotherapy for the treatment of previously untreated metastatic colorectal cancer in patient's greater than or equal to 70 years

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii113-ii114

2016

Volltextzugriff (PDF)

PD-030 Prospective non-interventional study to collect data on the use of bevacizumab and conventional chemotherapy for the treatment of previously untreated metastatic colorectal cancer in patient's ≥70 years

Annals of oncology, 2016-06, Vol.27, p.ii113

2016

Volltextzugriff (PDF)

PD-030Prospective non-interventional study to collect data on the use of bevacizumab and conventional chemotherapy for the treatment of previously untreated metastatic colorectal cancer in patient's ≥70 years

Annals of oncology, 2016-06, Vol.27 (Suppl 2), p.ii113-ii114

2016

Volltextzugriff (PDF)

PD-0568 PHASE II STUDY OF NEO ADJUVANT TREATMENT WITH AVASTIN, XELODA AND ELOXATIN IN RECTAL CANCER (AXE BEAM)

Radiotherapy and oncology, 2012-05, Vol.103, p.S227-S228

2012

Volltextzugriff (PDF)

Final Results of a Randomized Phase Ii Study with Neo-Adjuvant Triplet or Doublet Therapy, Radiation and Total Mesorectal Excision for Locally Advanced Rectal Cancer: Axe Beam

Annals of oncology, 2014-09, Vol.25, p.iv198

2014

Volltextzugriff (PDF)

579PFINAL RESULTS OF A RANDOMIZED PHASE II STUDY WITH NEO-ADJUVANT TRIPLET OR DOUBLET THERAPY, RADIATION AND TOTAL MESORECTAL EXCISION FOR LOCALLY ADVANCED RECTAL CANCER: AXE BEAM

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv198-iv199

2014

Volltextzugriff (PDF)

Axe Beam: Encouraging Early Results of a Neo-Adjuvant Bevacizumab, Capecitabine +/- Oxaliplatin and Radiation Multimodality Regimen for Locally Advanced Rectal Cancer

Annals of oncology, 2012-09, Vol.23, p.ix222

2012

Volltextzugriff (PDF)

663TiP - Axe Beam: Encouraging Early Results of a Neo-Adjuvant Bevacizumab, Capecitabine +/- Oxaliplatin and Radiation Multimodality Regimen for Locally Advanced Rectal Cancer

Annals of oncology, 2012-09, Vol.23, p.ix222-ix222

2012

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(17)
Humans
(13)
Male
(9)
Aged
(8)
Biological And Medical Sciences
(8)
Female
(8)
Adult
(7)
Middle Aged
(7)
Medical Sciences
(5)
Artemisia Annua
(4)
Chemotherapy
(4)
Genetic Engineering
(4)
Life Sciences
(4)
Oncology
(4)
Pharmacology. Drug Treatments
(4)
Plant Sciences
(4)
Prospective Studies
(4)
Antimalarials
(3)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treatment of patients with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC) in Belgium: a real world data analysis

Tilting a ground-state reactivity landscape by vibrational strong coupling

Intestinal schwannoma

Vaginal foreign body in the pediatric patient: A systematic review

Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial

Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015

Boerhaave's syndrome: successful conservative treatment in two patients

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials

The Psychological Science Accelerator: Advancing Psychology Through a Distributed Collaborative Network

A two arm phase II study of FOLFIRI in combination with standard or escalating dose of cetuximab as first line treatment for metastatic colorectal cancer: Everest 2 final results

REGINA: A phase II trial of neoadjuvant regorafenib (Rego) in combination with nivolumab (Nivo) and short-course radiotherapy (SCRT) in intermediate-risk, stage II-III rectal cancer (RC)

O-015A two arm phase II study of FOLFIRI in combination with standard or escalating dose of cetuximab as first line treatment for metastatic colorectal cancer: Everest 2 final results

AVAPLUS: Impact of geriatric assessment on first-line treatment duration (TD) and progression free survival (PFS) in mCRC patients ≥ 70 years

PD-030Prospective non-interventional study to collect data on the use of bevacizumab and conventional chemotherapy for the treatment of previously untreated metastatic colorectal cancer in patient's greater than or equal to 70 years

PD-030 Prospective non-interventional study to collect data on the use of bevacizumab and conventional chemotherapy for the treatment of previously untreated metastatic colorectal cancer in patient's ≥70 years

PD-030Prospective non-interventional study to collect data on the use of bevacizumab and conventional chemotherapy for the treatment of previously untreated metastatic colorectal cancer in patient's ≥70 years

PD-0568 PHASE II STUDY OF NEO ADJUVANT TREATMENT WITH AVASTIN, XELODA AND ELOXATIN IN RECTAL CANCER (AXE BEAM)

Final Results of a Randomized Phase Ii Study with Neo-Adjuvant Triplet or Doublet Therapy, Radiation and Total Mesorectal Excision for Locally Advanced Rectal Cancer: Axe Beam

579PFINAL RESULTS OF A RANDOMIZED PHASE II STUDY WITH NEO-ADJUVANT TRIPLET OR DOUBLET THERAPY, RADIATION AND TOTAL MESORECTAL EXCISION FOR LOCALLY ADVANCED RECTAL CANCER: AXE BEAM

Axe Beam: Encouraging Early Results of a Neo-Adjuvant Bevacizumab, Capecitabine +/- Oxaliplatin and Radiation Multimodality Regimen for Locally Advanced Rectal Cancer

663TiP - Axe Beam: Encouraging Early Results of a Neo-Adjuvant Bevacizumab, Capecitabine +/- Oxaliplatin and Radiation Multimodality Regimen for Locally Advanced Rectal Cancer

Suchergebnisse filtern